Clinical Trials Directory

Trials / Completed

CompletedNCT00856219

Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEnteral ContinuousContinuous Tube Feeding for 72 hours
DIETARY_SUPPLEMENTEnteral IntermittentIntermittent Tube Feedings
DIETARY_SUPPLEMENTParenteral ContinuousParenteral Continuously for 72 hours

Timeline

Start date
2009-02-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2009-03-05
Last updated
2015-05-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00856219. Inclusion in this directory is not an endorsement.